Medicxi Ventures Management (Jersey) LTD Rapt Therapeutics, Inc. Transaction History
Medicxi Ventures Management (Jersey) LTD
- $387 Million
- Q1 2025
A detailed history of Medicxi Ventures Management (Jersey) LTD transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Medicxi Ventures Management (Jersey) LTD holds 22,352,000 shares of RAPT stock, worth $18.1 Million. This represents 7.04% of its overall portfolio holdings.
Number of Shares
22,352,000
Previous 22,352,000
-0.0%
Holding current value
$18.1 Million
Previous $35.3 Million
22.79%
% of portfolio
7.04%
Previous 7.76%
Shares
1 transactions
Others Institutions Holding RAPT
# of Institutions
99Shares Held
134MCall Options Held
41.3KPut Options Held
100-
Orbimed Advisors LLC San Diego, CA13.1MShares$10.6 Million0.5% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA13.1MShares$10.6 Million3.85% of portfolio
-
Foresite Capital Management Vi LLC Larkspur, CA12.5MShares$10.1 Million8.35% of portfolio
-
Rtw Investments, LP New York, NY11.8MShares$9.53 Million0.24% of portfolio
-
Bvf Inc San Francisco, CA9.24MShares$7.48 Million0.5% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $24M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...